Imagion Biosystems
October 17, 2023
Franciscan D
Diagnostics
Company Description: Imagion Biosystems, Ltd. (ASX: IBX) is pioneering molecularly targeted MRI Contrast Agents with its MagSense® technology - a new functional imaging product line that holds the promise of being more sensitive and safer for detecting cancers and other critical diseases. Specialized bio-safe magnetic nanoparticles are coated with tumor-targeting molecules that are able to circulate through normal blood flow or local injection. When bound to a tumor the MagSense particles can then be detected by Magnetic Resonance Imaging scanners.
State
California
Country
United States
Website
https://imagionbiosystems.com/
CEO/Top Company Official
Isaac Bright
Lead Product in Development
MagSense HER2 Imaging Agent
Development Phase of Primary Product
Phase II
Number Of Unlicensed Products
4
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)